Olema Pharmaceuticals Inc (OLMA) USD0.0001

Sell:$25.42Buy:$28.77$2.88 (9.35%)

NASDAQ:1.31%
Market closed |
Prices delayed by at least 15 minutes
Sell:$25.42
Buy:$28.77
Change:$2.88 (9.35%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$25.42
Buy:$28.77
Change:$2.88 (9.35%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
10,000$8.33$83,300.00744,140
18 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
3,086$8.32$25,675.52117,028
16 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
10,000$8.04$80,400.00754,140
16 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
1,914$8.08$15,465.12120,114
8 January 2025
BAIN CAPITAL LIFE SCIENCES INVESTORS LLCPrivate Equity
Buy
Regular purchase transaction
300,000$5.76$1,727,370.007,800,000

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 January 2025
BAIN CAPITAL LIFE SCIENCES INVESTORS LLCPrivate Equity
Buy
Regular purchase transaction
300,000$5.76$1,727,370.007,800,000
18 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
10,000$8.33$83,300.00744,140
16 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
10,000$8.04$80,400.00754,140
18 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
3,086$8.32$25,675.52117,028
16 September 2025
Cyrus L. HarmonOther Level A
Sell
Regular sell transaction (market)
1,914$8.08$15,465.12120,114

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.